Advertisement
Advertisement
IMVT
Immunovant, Inc. Common Stock
38.22
USDSponsored
+0.60
+1.59%
Jun 24, 16:00 UTC -4
Closed
After-Market
38.22
0.00
-0.01%
IMVT Earnings Reports
Positive Surprise Ratio
IMVT beat 11 of 25 last estimates.
44%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q1 27 (Revenue/ EPS)
--
/-$0.61
Implied change from Q4 26 (Revenue/ EPS)
--
/-16.44%
Implied change from Q1 26 (Revenue/ EPS)
--
/-14.08%
Immunovant, Inc. Common Stock earnings per share and revenue
On May 20, 2026, IMVT reported earnings of -0.73 USD per share (EPS) for Q4 26, missing the estimate of -0.61 USD, resulting in a -19.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +35.26% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 10 analysts forecast an EPS of -0.61 USD, with revenue projected to reach -- USD, implying an decrease of -16.44% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Immunovant, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Immunovant, Inc. Common Stock reported EPS of -$0.73, missing estimates by -19.11%, and revenue of $0.00, 0% as expectations.
How did the market react to Immunovant, Inc. Common Stock's Q4 2026 earnings?
The stock price moved up 35.26%, changed from $26.29 before the earnings release to $35.56 the day after.
When is Immunovant, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Immunovant, Inc. Common Stock's next earnings report?
Based on 10
analysts, Immunovant, Inc. Common Stock is expected to report EPS of -$0.61 and revenue of -- for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement